Document is current

Article History

Received: 8 July 2025

Accepted: 22 August 2025

First Online: 6 September 2025

Declarations

:

: Bernhard Taxer, Wanda Lauth and Harry von Piekartz declare no conflict of interest. Stefan Leis has participated in meetings sponsored by or received speaker honoraria or travel funding from Allergan AbbVie, Lilly, Merz, Neuraxpharm, Novartis, Pfizer and TEVA and received honoraria for consulting from Allergan AbbVie, Lilly, Lundbeck and Orion. Eugen Trinka is an Editorial Board member of Neurology and Therapy. Eugen Trinka was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions.

: Prior to their participation in the study, written informed consent was obtained from all participants. After reviewing the requested information, the responsible ethics committee for the Federal State of Salzburg issued a positive vote on the ethics application and approved it on 30 August 2021, with the authorization being valid for 1 year (EC no. 1122/2021). The study was conducted in accordance with the Helsinki Declaration of 1964 and its later amendments, and it was not pre-registered on any clinical study registry. All questionnaires used were license-free, could be downloaded free of charge and did not require approval.